This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics 2014. CA Cancer J Clin 2014; 64: 9-29.SiegelRMaJZouZJemalACancer statistics 2014CA Cancer J Clin20146492910.3322/caac.21208Search in Google Scholar
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-403.FerlayJSteliarova-FoucherELortet-TieulentJRossoSCoeberghJWWComberHCancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012Eur J Cancer201349137440310.1016/j.ejca.2012.12.027Search in Google Scholar
Planchard D, Le Péchoux C. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment. Eur J Cancer 2011; 47(Suppl 3): S272-83.PlanchardDLe PéchouxCSmall cell lung cancer: new clinical recommendations and current status of biomarker assessmentEur J Cancer201147Suppl 3S2728310.1016/S0959-8049(11)70173-3Search in Google Scholar
Kalemkerian GP. Advances in the treatment of small-cell lung cancer. Semin Respir Crit Care Med 2011; 32: 94-101.KalemkerianGPAdvances in the treatment of small-cell lung cancerSemin Respir Crit Care Med2011329410110.1055/s-0031-127287321500128Search in Google Scholar
Foster NR, Mandrekar SJ, Schild SE, Nelson GD, Rowland KM Jr, Deming RL, et al. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer 2009; 115: 2721-31.FosterNRMandrekarSJSchildSENelsonGDRowlandKMJrDemingRLPrognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trialsCancer200911527213110.1002/cncr.24314277969419402175Search in Google Scholar
Knez L, Sodja E, Kern I, Košnik M, Cufer T. Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic review. Lung Cancer 2011; 72: 271-9.KnezLSodjaEKernIKošnikMCuferTPredictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic reviewLung Cancer201172271910.1016/j.lungcan.2011.02.01421440950Search in Google Scholar
Sodja E, Knez L, Kern I, Ovčariček T, Sadikov A, Cufer T. Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy. Eur J Cancer 2012; 48: 3378-85.SodjaEKnezLKernIOvčaričekTSadikovACuferTImpact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapyEur J Cancer20124833788510.1016/j.ejca.2012.06.01122795264Search in Google Scholar
Berns A. Stem cells for lung cancer? Cell 2005; 121: 811-3.BernsAStem cells for lung cancer?Cell2005121811310.1016/j.cell.2005.06.00415960966Search in Google Scholar
Pine SR, Marshall B, Varticovski L. Lung cancer stem cells. Dis Markers 2008; 24: 257-66.PineSRMarshallBVarticovskiLLung cancer stem cellsDis Markers2008242576610.1155/2008/396281385054118525120Search in Google Scholar
Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506-11.PontiDCostaAZaffaroniNPratesiGPetrangoliniGCoradiniDIsolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell propertiesCancer Res20056555061110.1158/0008-5472.CAN-05-062615994920Search in Google Scholar
Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-708.PatrawalaLCalhounTSchneider-BroussardRLiHBhatiaBTangSHighly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cellsOncogene200625169670810.1038/sj.onc.120932716449977Search in Google Scholar
Li C, Heidt DG, Dalerba P, Burnat CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-7.LiCHeidtDGDalerbaPBurnatCFZhangLAdsayVIdentification of pancreatic cancer stem cellsCancer Res2007671030710.1158/0008-5472.CAN-06-203017283135Search in Google Scholar
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504-14.EramoALottiFSetteGPilozziEBiffoniMDi VirgilioAIdentification and expansion of the tumorigenic lung cancer stem cell populationCell Death Differ2008155041410.1038/sj.cdd.440228318049477Search in Google Scholar
Lu Y, Futtner C, Rock JR, Xu X, Whitworth W, Hogan BLM, et al. Evidence that SOX2 overexpression is oncogenic in the lung. PLos One 2010; 5: e11022.LuYFuttnerCRockJRXuXWhitworthWHoganBLMEvidence that SOX2 overexpression is oncogenic in the lungPLos One20105e1102210.1371/journal.pone.0011022288355320548776Search in Google Scholar
Gialmanidis IP, Bravou V, Petrou I, Kourea H, Mathioudakis A, Lilis I, et al. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer. Lung 2013; 191:511-21.GialmanidisIPBravouVPetrouIKoureaHMathioudakisALilisIExpression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancerLung20131915112110.1007/s00408-013-9490-423864317Search in Google Scholar
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133positive cells. PLos One 2008; 3: e2637.ChenYCHsuHSChenYWTsaiTHHowCKWangCYOct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133positive cellsPLos One20083e263710.1371/journal.pone.0002637244080718612434Search in Google Scholar
Sullivan JP, Minna JD, Shay JW. Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev 2010; 29: 61-72.SullivanJPMinnaJDShayJWEvidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapyCancer Metastasis Rev201029617210.1007/s10555-010-9216-5286458120094757Search in Google Scholar
Bertolini G, Roz L, Perego P, Tortoeto M, Fontanella E, Gatti L, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci 2009; 106: 16281-6.BertoliniGRozLPeregoPTortoetoMFontanellaEGattiLHighly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentProc Natl Acad Sci200910616281610.1073/pnas.0905653106274147719805294Search in Google Scholar
Stewart DJ. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol 2010; 75: 173-234.StewartDJTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerCrit Rev Oncol Hematol20107517323410.1016/j.critrevonc.2009.11.006288863420047843Search in Google Scholar
Wu Y, Du X, Xue C, Li D, Zheng Q, Li X, et al. Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer. Med Oncol 2013; 30: 737.WuYDuXXueCLiDZhengQLiXQuantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancerMed Oncol20133073710.1007/s12032-013-0737-y24126941Search in Google Scholar
Velcheti V, Schalper K, Yao X, Cheng H, Kocoglu M, Dhodapkar K, et al. High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One 2013; 8: e61427.VelchetiVSchalperKYaoXChengHKocogluMDhodapkarKHigh SOX2 levels predict better outcome in non-small cell lung carcinomasPLoS One20138e6142710.1371/journal.pone.0061427363123823620753Search in Google Scholar
Chen Y, Huang Y, Huang Y, Chen J, Wang S, Zhou J. The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis. PLoS One 2013; 8: e71140.ChenYHuangYHuangYChenJWangSZhouJThe prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysisPLoS One20138e7114010.1371/journal.pone.0071140374720123990933Search in Google Scholar
Yang F, Gao Y, Geng J, Qu D, Han Q, Qi J, et al. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer. Int J Clin Exp Pathol 2013; 6: 2846-54.YangFGaoYGengJQuDHanQQiJElevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancerInt J Clin Exp Pathol20136284654Search in Google Scholar
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, et al. Coexpression of oct4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 2010; 70: 10433-44.ChiouSHWangMLChouYTChenCJHongCFHsiehWJCoexpression of oct4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiationCancer Res201070104334410.1158/0008-5472.CAN-10-263821159654Search in Google Scholar
Li XQ, Yang XL, Zhang G, Wu SP, Deng XB, Xiao SJ, et al. Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer. J Transl Med 2013; 11: 114.LiXQYangXLZhangGWuSPDengXBXiaoSJNuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancerJ Transl Med20131111410.1186/1479-5876-11-114370634723648139Search in Google Scholar
Li XL, Jia LL, Shi MM, Li X, Li ZH, Li HF, et al. Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression. J Transl Med 2013; 11: 232.LiXLJiaLLShiMMLiXLiZHLiHFDownregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expressionJ Transl Med20131123210.1186/1479-5876-11-232384926324070213Search in Google Scholar
Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, Maier S, et al. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 2011; 24: 944-53.WilbertzTWagnerPPetersenKStiedlACSchebleVJMaierSSOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerMod Pathol2011249445310.1038/modpathol.2011.4921460799Search in Google Scholar
Tian Y, Jia X, Wang S, Li Y, Zhao P, Cai D, et al. SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness. J Cancer Res Clin Oncol 2014; 140: 1117-24.TianYJiaXWangSLiYZhaoPCaiDSOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsivenessJ Cancer Res Clin Oncol201414011172410.1007/s00432-014-1660-024752338Search in Google Scholar
Chou YT, Lee CC, Hsiao SH, Lin SE, Lin SC, Chung CH, et al. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells 2013; 31: 2607-19.ChouYTLeeCCHsiaoSHLinSELinSCChungCHThe emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancerStem Cells20133126071910.1002/stem.151823940081Search in Google Scholar
Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembelé D, et al. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 2010; 5: e8960.HussenetTDaliSExingerJMongaBJostBDembeléDSOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomasPLoS One20105e896010.1371/journal.pone.0008960281330020126410Search in Google Scholar
Toschi L, Finocchiaro G, Nguyen TT, Skokan MC, Giordano L, Gianoncelli L, et al. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease. PLoS One 2014; 9: e95303.ToschiLFinocchiaroGNguyenTTSkokanMCGiordanoLGianoncelliLIncreased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage diseasePLoS One20149e9530310.1371/journal.pone.0095303398817324736592Search in Google Scholar
Cai YR, Zhang HQ, Zhang ZD, Mu J, Li ZH. Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma. Oncol Lett 2011; 2: 257-64.CaiYRZhangHQZhangZDMuJLiZHDetection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinomaOncol Lett201122576410.3892/ol.2010.229341056622866074Search in Google Scholar
Sasaki H, Yokota K, Hikosaka Y, Moriyama S, Yano M, Fujii Y. Increased Sox2 copy number in lung squamous cell carcinomas. Exp Ther Med 2012; 3:44-8.SasakiHYokotaKHikosakaYMoriyamaSYanoMFujiiYIncreased Sox2 copy number in lung squamous cell carcinomasExp Ther Med2012344810.3892/etm.2011.374343885422969842Search in Google Scholar
Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA, Ling TY, et al. Pulmonary adenocarcinoma in malignant pleural effusion enriches cancer stem cell properties during metastatic cascade. PLoS One 2013; 8: e54659.ChenWJHoCCChangYLChenHYLinCALingTYPulmonary adenocarcinoma in malignant pleural effusion enriches cancer stem cell properties during metastatic cascadePLoS One20138e5465910.1371/journal.pone.0054659364105423658677Search in Google Scholar
Du Y, Ma C, Wang Z, Liu Z, Liu H, Wang T. Nanog, a novel prognostic marker for lung cancer. Surg Oncol 2013; 22: 224-9.DuYMaCWangZLiuZLiuHWangTNanog, a novel prognostic marker for lung cancerSurg Oncol201322224910.1016/j.suronc.2013.08.00124018162Search in Google Scholar
Li X, Wang J, Xu Z, Ahmad A, Li E, Wang Y, et al. Expression of sox2 and oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci 2012; 13: 7663-75.LiXWangJXuZAhmadALiEWangYExpression of sox2 and oct4 and their clinical significance in human non-small-cell lung cancerInt J Mol Sci20121376637510.3390/ijms13067663339755222837720Search in Google Scholar
Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-37.SchwarzenbachHHoonDSPantelKCell-free nucleic acids as biomarkers in cancer patientsNat Rev Cancer2011114263710.1038/nrc306621562580Search in Google Scholar
Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358: 502-11CroceCMOncogenes and cancerN Engl J Med20083585021110.1056/NEJMra07236718234754Search in Google Scholar
Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.JonesPABaylinSBThe epigenomics of cancerCell20071286839210.1016/j.cell.2007.01.029389462417320506Search in Google Scholar
Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration. PLoS Med 2012; 9: e1001216.AltmanDGMcShaneLMSauerbreiWTaubeSEReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLoS Med20129e100121610.1371/journal.pmed.1001216336208522675273Search in Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47.EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer2009452284710.1016/j.ejca.2008.10.02619097774Search in Google Scholar
Sequist LV, Heist RS, Shaw AT, Fidias P, Rosovsky R, Temel JS, et al. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol 2011; 22: 2616-24.SequistLVHeistRSShawATFidiasPRosovskyRTemelJSImplementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practiceAnn Oncol20112226162410.1093/annonc/mdr489349313022071650Search in Google Scholar
Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 2006; 24: 1754-60.LiYElashoffDOhMSinhaUSt JohnMAZhouXSerum circulating human mRNA profiling and its utility for oral cancer detectionJ Clin Oncol20062417546010.1200/JCO.2005.03.759816505414Search in Google Scholar
Beane J, Spira A, Lenburg ME. Clinical impact of high-throughput gene expression studies in lung cancer. J Thorac Oncol 2009; 4: 109-18.BeaneJSpiraALenburgMEClinical impact of high-throughput gene expression studies in lung cancerJ Thorac Oncol200941091810.1097/JTO.0b013e31819151f8273141319096318Search in Google Scholar
Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001; 98: 13784-9.GarberMETroyanskayaOGSchluensKPetersenSThaeslerZPacyna-GengelbachMDiversity of gene expression in adenocarcinoma of the lungProc Natl Acad Sci U S A20019813784910.1073/pnas.2415007986111911707590Search in Google Scholar
Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001; 98: 13790-5.BhattacharjeeARichardsWGStauntonJLiCMontiSVasaPClassification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesProc Natl Acad Sci U S A20019813790510.1073/pnas.1915029986112011707567Search in Google Scholar
Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 2009; 16: 3488-98.SaigusaSTanakaKToiyamaYYokoeTOkugawaYIoueYCorrelation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapyAnn Surg Oncol20091634889810.1245/s10434-009-0617-z19657699Search in Google Scholar
Fujimura T, Takahashi S, Urano T, Takayama K, Sugihara T, Obinata D, et al. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer. Clin Cancer Res 2014; 20: 4625-35.FujimuraTTakahashiSUranoTTakayamaKSugiharaTObinataDExpression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancerClin Cancer Res20142046253510.1158/1078-0432.CCR-13-110524987058Search in Google Scholar
Huang P, Qiu J, Li B, Hong J, Lu C, Wang L, et al. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem 2011; 44: 582-9.HuangPQiuJLiBHongJLuCWangLRole of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomyClin Biochem201144582910.1016/j.clinbiochem.2011.02.01221376027Search in Google Scholar
Zhao S, Yuan Q, Hao H, Guo Y, Liu S, Zhang Y, et al. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. J Pathol 2011; 223: 672-82.ZhaoSYuanQHaoHGuoYLiuSZhangYExpression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinomaJ Pathol20112236728210.1002/path.282721341266Search in Google Scholar
Uchino K, Hirano G, Hirahashi M, Isobe T, Shirakawa T, Kusaba H, et al. Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp Cell Res 2012; 318: 1799-807.UchinoKHiranoGHirahashiMIsobeTShirakawaTKusabaHHuman Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cellsExp Cell Res2012318179980710.1016/j.yexcr.2012.04.01122677041Search in Google Scholar
